Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe for Chronic Hepatitis D
NCT03099278Phase 2Unknown
- Sponsor
- Ziauddin Hospital
- Start
- Jan 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ezetimibe in chronic hepatitis D, sponsored by Ziauddin Hospital. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
chronic hepatitis D
Beyond the preview
Go deeper on NCT03099278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03099278.